136 related articles for article (PubMed ID: 10202211)
1. Approaches to the modulation of abdominal pain.
Mayer EA; Lembo T; Chang L
Can J Gastroenterol; 1999 Mar; 13 Suppl A():65A-70A. PubMed ID: 10202211
[TBL] [Abstract][Full Text] [Related]
2. Brain-gut interactions: implications for newer therapy.
Mayer EA; Chang L; Lembo T
Eur J Surg Suppl; 1998; (582):50-5. PubMed ID: 10029365
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.
Sanger GJ
Dig Dis; 1999; 17(2):90-9. PubMed ID: 10545714
[TBL] [Abstract][Full Text] [Related]
4. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ
Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
[TBL] [Abstract][Full Text] [Related]
5. [Serotonin may be the key to the treatment of "irritable bowel disease"].
Sjövall H
Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
[No Abstract] [Full Text] [Related]
6. Novel medications for the irritable bowel syndrome: motility and sensation.
Camilleri M
J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
[No Abstract] [Full Text] [Related]
7. New and future drugs in nerve-gut dysfunction.
Bueno L
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):794-801. PubMed ID: 10730572
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
[TBL] [Abstract][Full Text] [Related]
9. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
Delvaux M; Frexinos J
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
[No Abstract] [Full Text] [Related]
10. [Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
Matsueda K
Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1146-53. PubMed ID: 11680988
[No Abstract] [Full Text] [Related]
11. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
[No Abstract] [Full Text] [Related]
12. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.
Kindt S; Tack J
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():32-9. PubMed ID: 17620086
[TBL] [Abstract][Full Text] [Related]
13. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and neuroprotection in functional bowel disorders.
Gershon MD; Liu MT
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2(Suppl 2):19-24. PubMed ID: 17620084
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy options for patients with irritable bowel syndrome.
Talley NJ
Am J Manag Care; 2001 Jul; 7(8 Suppl):S261-7. PubMed ID: 11474911
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.
Mearin F
Digestion; 2006; 73 Suppl 1():28-37. PubMed ID: 16498250
[TBL] [Abstract][Full Text] [Related]
17. Role of serotonin in gastrointestinal physiology and pathology.
Cirillo C; Vanden Berghe P; Tack J
Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
[TBL] [Abstract][Full Text] [Related]
18. New pharmacologic therapies in gastrointestinal disease.
Wallace JL; Ferraz JG
Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926
[TBL] [Abstract][Full Text] [Related]
19. [Colonic microflora and motility. Physiological data and during irritable bowel syndrome].
Coffin B
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C85-8. PubMed ID: 11787386
[No Abstract] [Full Text] [Related]
20. Treatment goals in irritable bowel syndrome.
Kellow JE
Int J Clin Pract; 2001 Oct; 55(8):546-51. PubMed ID: 11695076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
